How to Invest $250,000

How to Invest $250,000: the allocation questions that matter before product selection, and where pre-IPO funds do and don't fit a $250,000 portfolio. This page does not tell you what to buy. It walks through the decisions that determine whether a $250,000 allocation works, then shows where pre-IPO exposure fits if it fits at all.

Start with constraints, not products

The most common mistake with a sum like $250,000 is starting from a product list. Work the constraints first, because they eliminate most options quickly and leave a much shorter shortlist to evaluate properly.

When do you need it back? Money required within five years should not go anywhere illiquid.

Where pre-IPO funds fit in your portfolio

Exposure through pre-IPO funds is a satellite holding, not a core one. It is illiquid, undiversified at the single-name level, and priced with poor information relative to anything listed.

A framework for investing $250,000

Rather than prescribe percentages, work through the sequence. First, settle liquidity: hold enough cash that no market event forces a sale. Second, build the core public portfolio that does the actual compounding. Only then size a private sleeve from what genuinely remains.

Model the fee drag on any private allocation with our fee calculator and size the sleeve with the allocation calculator before committing.

What $250,000 gets you in pre-IPO funds

Ticket size determines structure. Smaller amounts are generally limited to listed funds holding private companies, or to pooled vehicles. Larger amounts open direct secondary purchases, which carry higher minimums but give you the underlying security.

What $250,000 looks like across structures

Ticket size is the practical constraint that decides which structures are open to you, and the differences at $250,000 are larger than most people expect before they start comparing.

At the lower end of private-market access, listed vehicles holding pre-IPO companies are the realistic route: you buy them like any security, exposure to a single name is diluted, and you keep daily liquidity. Pooled vehicles come next, then direct secondaries at the top of the range.

The important point is that $250,000 spread across three or four positions behaves very differently from the same amount concentrated in one. Given how dispersed outcomes are in this asset class, the spread version is almost always the more defensible choice.

How long the money is committed

Assume any private allocation is unavailable for at least five years, and possibly considerably longer. Companies stay private far longer than they did a decade ago, and the exit you are underwriting may simply not arrive on the timetable anyone quoted.

That has a practical consequence for how you fund the position. Capital with a known future use - a deposit, school fees, a business commitment - should never be the capital you commit here, regardless of how attractive the opportunity looks.

Run the timeline honestly with the ROI calculator: add two years to whatever exit you are told to expect, and check whether the return still justifies the wait.

Sizing the position honestly

There is no formula that produces the right allocation, but there is a test that reliably identifies the wrong one: if a total loss on the position would change your plans, the position is too large.

That test matters because outcome dispersion in private markets is extreme. A minority of positions drive most of the returns while others return little or nothing, and you cannot know in advance which is which.

In practice this pushes most investors toward a smaller sleeve spread over more positions than their conviction suggests. That feels unsatisfying - conviction wants concentration - but it is the structure that survives the arithmetic of this asset class.

Liquidity before everything else

Before any allocation decision, settle the liquidity question, because getting it wrong invalidates everything downstream. The test is simple: if you can name a use for this money in the next five years, it does not belong in a private position.

This matters more in private markets than anywhere else because the failure mode is specific and irreversible. In public markets a forced sale costs you the spread and a bad price. In private markets there may be no buyer at any price.

The investors who do badly here are rarely the ones who picked poor companies. They are the ones who committed capital they turned out to need, and then discovered there was no way to get it back.

A note on sequencing

The order in which you deploy matters as much as the allocation itself. Deploying an entire sleeve into one market mood concentrates timing risk in a way that is entirely avoidable by staging entry over several quarters.

It also gives you something more valuable than diversification: information. The first position teaches you how a provider actually reports, how long settlement really takes, and whether the fee schedule matched the sales conversation.

Investors who commit everything at once and learn the process afterwards are the ones who discover a structural problem at exit, when nothing can be done about it.

Pre-IPO investing mistakes that cost the most

Over-sizing. Enthusiasm for a company name is not a position-sizing method. Ignoring the wrapper. Two investors buying the same company in the same week can get materially different outcomes because of the structure they used. Assuming the timeline. Add years to whatever exit date you are told.

Frequently asked questions